PL1857120T3 - Infuzje do leczenia zapalenia gruczołów mlekowych - Google Patents

Infuzje do leczenia zapalenia gruczołów mlekowych

Info

Publication number
PL1857120T3
PL1857120T3 PL06711869T PL06711869T PL1857120T3 PL 1857120 T3 PL1857120 T3 PL 1857120T3 PL 06711869 T PL06711869 T PL 06711869T PL 06711869 T PL06711869 T PL 06711869T PL 1857120 T3 PL1857120 T3 PL 1857120T3
Authority
PL
Poland
Prior art keywords
mastitis
infusion
Prior art date
Application number
PL06711869T
Other languages
English (en)
Inventor
Junko Tsukada
Eiichi Ohashi
Tomio Matsunaga
Original Assignee
Nippon Zenyaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zenyaku Kogyo Co Ltd filed Critical Nippon Zenyaku Kogyo Co Ltd
Publication of PL1857120T3 publication Critical patent/PL1857120T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL06711869T 2005-01-19 2006-01-18 Infuzje do leczenia zapalenia gruczołów mlekowych PL1857120T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005011646 2005-01-19
PCT/JP2006/300600 WO2006077856A1 (ja) 2005-01-19 2006-01-18 乳房炎用注入剤
EP06711869A EP1857120B1 (en) 2005-01-19 2006-01-18 Infusion for mastitis

Publications (1)

Publication Number Publication Date
PL1857120T3 true PL1857120T3 (pl) 2012-05-31

Family

ID=36692245

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06711869T PL1857120T3 (pl) 2005-01-19 2006-01-18 Infuzje do leczenia zapalenia gruczołów mlekowych

Country Status (9)

Country Link
US (1) US20090005448A1 (pl)
EP (1) EP1857120B1 (pl)
JP (1) JP5037948B2 (pl)
KR (1) KR101232101B1 (pl)
CN (1) CN101107015B (pl)
DK (1) DK1857120T3 (pl)
ES (1) ES2377878T3 (pl)
PL (1) PL1857120T3 (pl)
WO (1) WO2006077856A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5439638B2 (ja) * 2009-05-19 2014-03-12 Adekaクリーンエイド株式会社 乳房炎治療剤
CN103230365B (zh) * 2013-03-19 2014-12-03 中国牧工商(集团)总公司 一种在干奶期用于预防奶牛隐性乳腺炎的缓释乳房灌注剂
JP7360656B2 (ja) * 2019-08-29 2023-10-13 国立研究開発法人農業・食品産業技術総合研究機構 乳房炎用注入剤
CN114404365B (zh) * 2022-01-18 2023-03-14 山东鲁抗舍里乐药业有限公司 头孢洛宁乳房注入剂及其制备方法和应用
CN115715760A (zh) * 2022-12-22 2023-02-28 河北科星药业有限公司 一种乳房注入剂的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2804421A (en) * 1951-04-24 1957-08-27 American Cyanamid Co Tetracycline type antibiotic ointment
US4034099A (en) * 1974-03-29 1977-07-05 The Upjohn Company Compositions and method for treating mastitis in milk animals
JPS5283924A (en) * 1976-01-01 1977-07-13 Sumitomo Chem Co Ltd Preparation of pharmaceuticals for rectal infusion containing penicill ins and cephalosporins
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
JPS56100712A (en) * 1980-01-18 1981-08-12 Sankyo Co Ltd Preparation of pharmaceutical of 7-methoxycephalosporin for rectal administration
JPS56104812A (en) * 1980-01-23 1981-08-20 Sankyo Co Ltd Production of cephalosporin compound preparation for rectal infusion
GB8629481D0 (en) * 1986-12-10 1987-01-21 Beecham Group Plc Veterinary treatment
HU199682B (en) * 1988-04-01 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producin synergetic veterinary composition
JPH05283924A (ja) 1992-03-31 1993-10-29 Nippon Telegr & Teleph Corp <Ntt> アレーアンテナ
JPH08175989A (ja) * 1994-12-26 1996-07-09 Nissan Gosei Kogyo Kk 乳房炎の予防のための組成物
JP2001501181A (ja) * 1996-09-06 2001-01-30 ミネソタ マイニング アンド マニュファクチャリング カンパニー 抗微生物組成物
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
BR0316776A (pt) * 2002-12-10 2005-10-25 Biosynexus Inc Formula para anti-infeccioso tópico
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
JP4252497B2 (ja) * 2004-06-07 2009-04-08 日東電工株式会社 上部消化管内視鏡検査前処置用局所麻酔製剤

Also Published As

Publication number Publication date
US20090005448A1 (en) 2009-01-01
JPWO2006077856A1 (ja) 2008-06-19
EP1857120B1 (en) 2011-12-28
ES2377878T3 (es) 2012-04-02
JP5037948B2 (ja) 2012-10-03
CN101107015B (zh) 2013-01-23
EP1857120A1 (en) 2007-11-21
KR20070106522A (ko) 2007-11-01
EP1857120A4 (en) 2008-10-22
CN101107015A (zh) 2008-01-16
DK1857120T3 (da) 2012-04-10
WO2006077856A1 (ja) 2006-07-27
KR101232101B1 (ko) 2013-02-12

Similar Documents

Publication Publication Date Title
IL180417A0 (en) Teat
PL1981866T3 (pl) N-Cyklopropylo-N-benzyloamidy jako środki grzybobójcze
ZA200800817B (en) Insecticidal 3-acylaminobenzanilides
GB0614691D0 (en) Insecticidal compounds
GB0612713D0 (en) Insecticidal compounds
PL1951334T3 (pl) Laktator
EP1849490A4 (en) SYRINGE
EP1879634A4 (en) IMPROVED SYRINGE
EP1873009A4 (en) TRACTOR
IL197147A0 (en) Fungicides
EP1933611A4 (en) AGRICULTURAL MACHINE
EP1844804A4 (en) SYRINGE
GB2429622B (en) Raised Flowerbed System
AP2337A (en) Motilide compounds.
DK1857120T3 (da) Infusion til mastitis
GB0526153D0 (en) Planter
GB0403727D0 (en) Teat
GB0414560D0 (en) Teat
GB2429624B (en) Lawnmower
GB2429623B (en) Lawnmower
GB0516414D0 (en) Self-retracting teat
ZA200903454B (en) Insecticidal compounds
AP2009004837A0 (en) Kenrock planters
GB0617858D0 (en) Insecticidal compounds
GB0509722D0 (en) Pieangle